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85 What is bacterial colonisation of cystic ﬁbrosis children
toothbrushes?
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Objectives: Pseudomonas aeruginosa or Staphylococcus aureus toothbrushes con-
tamination in cystic ﬁbrosis (CF) patients is unknown. The objective of this pilot
study was to determine prevalence of those germs on toothbrushes of CF and healthy
children, and deﬁne if toothbrushes may be involved in pulmonary infection.
Methods: Toothbrushes and sputum bacteriological analysis from children between
8 and 18 year old was conducted: 27 CF patients, 15 healthy siblings and 15 healthy
children out of patient family.
Results: Staphylococcus aureus has been identiﬁed on 23% toothbrushes from
patients, and 13% of healthy children, without any methicillin-resistant specimen.
P. aeruginosa was detected on 15% of patients toothbrushes, and 0% to 13% of
healthy children. There was no statistical link between pulmonary colonisation and
toothbrush contamination.
Conclusion: CF patient toothbrushes can be colonised by S. aureus or P. aeruginosa.
Impact on pulmonary colonisation is still unknown. Toothbrush decontamination
methods need to take into account these bacteria in CF patients.
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Objectives: Cystic ﬁbrosis (CF) is one of the most frequently diagnosed autosomal-
recessive diseases in the Caucasian population. Screening for Cystic Fibrosis
Transmembrane conductance Regulator (CFTR) gene mutations, including poly T,
is strongly recommended in infertile couples planning a pregnancy by assisted
reproductive technology (ART). This study evaluated the performance of the new
Nanochip CF70 kit (Savyon Diagnostic, Israel), a microarray assay, and compared
it with the Innolipa kits (Innogenetics, Belgium).
Methods: From January to July 2012 we analyzed 392 blood samples with
Innolipa and Nanochip technologies that identify respectively 70 and 56 CFTR
mutations. Both tests include the most common Italian mutations and the poly-T
screening. Discordant results were analyzed with the Devyser CFTR Core Kit
(Devyser, AB, Sweden), MLPA (MRC Holland), Direct Sequencing (DS) on the
3730 DNA Analyzer (AppliedBiosystems), and Sequenom’s MassArray system
(Diatechpharmacogenetics, Italy).
Results: Innolipa and NanoChip were concordant for 371/392 samples.
21/392 (0.5%) discordant results were tested with the aforementioned technologies:
DS conﬁrmed Innolipa results in 18/21 samples and Nanochip results in 1/21,
while Devyser and Sequenom did not recognize some mutations not included in
their panels. DS was essential for the identiﬁcation of two different homozygous
deletions; although they were not present in Innolipa panels, in 2/21 samples
Innolipa indicated a mutation with the warning no interpretation possible.
Conclusion: In this study the Innolipa assay conﬁrmed its reliability and Nanochip
showed that it could become competitive with slight changes to the software.
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Objectives: To apply the 16S rRNA pyrosequencing technique to identify bacterial
species of induced sputum (IS).
Methods: A total of 62 IS samples were collected from unrelated clinically stable
CF-patients [42 males, median age of 18.5 years ranged from 6 to 52, 21 of them
F508del homozygous (33.4%) and 28 heterozygous (45.1%)] attended in three
different CF-Units of Madrid, Spain (Hospital Ramo´n y Cajal n = 31, Hospital La
Princesa n = 21, and Hospital La Paz n = 10). Total DNA was obtained with a manual
protocol of extraction. Metagenomic proﬁles were determined using tag-encoded
16S rRNA gene and pyrosequenced by 454/FLX Titanium (Roche).
Results: From the 62 samples processed, 51 samples offered adequate quality
results. The median of the bacterial loads was 2,748 copies per IS sample (ranged
from 37 to 24,083). Taking account of all samples, the major bacterial Phyla
detected were Proteobacteria (78.71%) [g-Proteobacteria 74.13%, b-Proteobacteria
4.42, d-Proteobacteria 0.13%, and a-Proteobacteria 0.02%]; Firmicutes (15.03%);
Actinobacteria (3.23%); and ﬁnally Bacteroidetes (2.56%). In 41 subject, more than
50% of the total bacteria present in the sputum corresponded to the g-Proteobacteria
Class, in which is included the genus Pseudomonas. Detection of uncultured or not-
previously reported bacterium was anecdotic.
Conclusion: Metagenomic analysis of sputum samples corroborated that Pseudo-
monas aeruginosa (g-Proteobacteria) and Staphylococcus aureus (Firmicutes) are
the major pathogens present in the lung of CF-subjects. Nevertheless, a great intra-
individual diversity was found in both bacterial density and phylum’s proportions.
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Introduction: Cystic Fibrosis (CF) lung infection is polymicrobial, including
fastidious and slow growing anaerobic bacteria, poorly identiﬁed by conventional
methods. Matrix Assisted Laser Desorption Ionization Time-Of-Flight (MALDI-
TOF) is a powerful, rapid, precise and cost-effective method for bacteria identiﬁ-
cation.
Aim: To demonstrate that MALDI-TOF-MS could be a good option for identiﬁca-
tion of CF anaerobic bacteria.
Methods: CF respiratory samples were processed using both anaerobic and aerobic
bacteriological technique. Isolated microorganisms were identiﬁed by MALDI-TOF-
MS.
Results: 32 CF samples were collected from 32 CF patients (mean age 23 years,
range 1−50). Anaerobes from 12 different species were detected in 69% of
samples. The most representative bacteria belonged to Prevotella spp. (40%),
Veillonella spp. (22%), Gemella spp. (12%). Pseudomonas aeruginosa (Pa) was
isolated in 44% of CF studied patients.
Discussion: Despite of restricted number of samples, anaerobic ﬂora is not age-
related, furthermore anaerobic lung colonization seems not inﬂuenced by the
concomitant Pa infection. Different studies demonstrated the use of MALDI-TOF-
MS for routine identiﬁcation of anaerobic bacteria. These organisms are poorly
identiﬁed using phenotypic and molecular approaches. The extreme speed and low
cost of MALDI-TOF-MS could improve laboratory efﬁciency of anaerobic bacteria
identiﬁcation, relevant for efﬁcient treatment.
